Literature DB >> 32566998

Maternal Sociodemographic Factors Are Associated with Methylphenidate Initiation in Children in the Netherlands: A Population-Based Study.

K Cheung1,2, H El Marroun3,4,5, B Dierckx3, L E Visser6,7, B H Stricker6,8.   

Abstract

Multiple factors may contribute to the decision to initiate methylphenidate treatment in children such as maternal sociodemographic factors of which relatively little is known. The objective was to investigate the association between these factors and methylphenidate initiation. The study population included 4243 children from the Generation R Study in the Netherlands. Maternal sociodemographic characteristics were tested as determinants of methylphenidate initiation through a time-dependent Cox regression analysis. Subsequently, we stratified by mother-reported ADHD symptoms (present in 4.2% of the study population). When ADHD symptoms were absent, we found that girls (adjusted HR 0.25, 95%CI 0.16-0.39) and children born to a mother with a non-western ethnicity (compared to Dutch-Caucasian) (adjusted HR 0.42, 95%CI 015-0.68) were less likely to receive methylphenidate. They were more likely to receive methylphenidate when their mother completed a low (adjusted HR 2.29, 95%CI 1.10-4.77) or secondary (adjusted HR 1.71, 95%CI 1.16-2.54) education. In conclusion, boys and children born to a mother of Dutch-Caucasian ethnicity were more likely to receive methylphenidate, irrespective of the presence of ADHD symptoms.

Entities:  

Keywords:  Attention deficit hyperactivity disorder; Child; Initiation; Medication; Methylphenidate

Mesh:

Substances:

Year:  2021        PMID: 32566998      PMCID: PMC7973638          DOI: 10.1007/s10578-020-01016-2

Source DB:  PubMed          Journal:  Child Psychiatry Hum Dev        ISSN: 0009-398X


  56 in total

Review 1.  Annual Research Review: Maternal antidepressant use during pregnancy and offspring neurodevelopmental problems - a critical review and recommendations for future research.

Authors:  Ayesha C Sujan; A Sara Öberg; Patrick D Quinn; Brian M D'Onofrio
Journal:  J Child Psychol Psychiatry       Date:  2018-12-05       Impact factor: 8.982

2.  The Association Between Race/Ethnicity and Socioeconomic Factors and the Diagnosis and Treatment of Children with Attention-Deficit Hyperactivity Disorder.

Authors:  Ami C Bax; David E Bard; Steven P Cuffe; Robert E McKeown; Mark L Wolraich
Journal:  J Dev Behav Pediatr       Date:  2019 Feb/Mar       Impact factor: 2.225

3.  Geographic variation in receipt of psychotherapy in children receiving attention-deficit/hyperactivity disorder medications.

Authors:  Walid F Gellad; Bradley D Stein; Teague Ruder; Rochelle Henderson; Sharon G Frazee; Ateev Mehrotra; Julie M Donohue
Journal:  JAMA Pediatr       Date:  2014-11       Impact factor: 16.193

4.  The Brief Symptom Inventory: an introductory report.

Authors:  L R Derogatis; N Melisaratos
Journal:  Psychol Med       Date:  1983-08       Impact factor: 7.723

5.  ADHD in Germany: Trends in Diagnosis and Pharmacotherapy.

Authors:  Christian J Bachmann; Alexandra Philipsen; Falk Hoffmann
Journal:  Dtsch Arztebl Int       Date:  2017-03-03       Impact factor: 5.594

6.  Maternal smoking during pregnancy and attention deficit hyperactivity disorder symptoms in offspring.

Authors:  Anita Thapar; Tom Fowler; Frances Rice; Jane Scourfield; Marianne van den Bree; Hollie Thomas; Gordon Harold; Dale Hay
Journal:  Am J Psychiatry       Date:  2003-11       Impact factor: 18.112

7.  Perceptions of girls and ADHD: results from a national survey.

Authors:  Patricia Quinn; Sharon Wigal
Journal:  MedGenMed       Date:  2004-05-04

8.  Parental perceptions and satisfaction with stimulant medication for attention-deficit hyperactivity disorder.

Authors:  Susan Dosreis; Julie Magno Zito; Daniel J Safer; Karen L Soeken; John W Mitchell; Leslie C Ellwood
Journal:  J Dev Behav Pediatr       Date:  2003-06       Impact factor: 2.225

9.  Evaluation of attention-deficit hyperactivity disorder risk factors.

Authors:  Javad Golmirzaei; Shole Namazi; Shahrokh Amiri; Shahram Zare; Najme Rastikerdar; Ali Akbar Hesam; Zahra Rahami; Fatemeh Ghasemian; Seyyed Shojaeddin Namazi; Abbas Paknahad; Forugh Mahmudi; Hamidreza Mahboobi; Tahereh Khorgoei; Bahareh Niknejad; Fatemeh Dehghani; Shima Asadi
Journal:  Int J Pediatr       Date:  2013-11-10

10.  Barriers and predictors of medication use for childhood ADHD: findings from a UK population-representative cohort.

Authors:  A E Russell; T Ford; G Russell
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2019-05-09       Impact factor: 4.328

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.